MVA-nef

Modified Vaccinia Ankara vector expressing HIV-1 nef gene · Bavarian Nordic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA-nef, covering 2012-10-01 to 2012-10-01. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients [Phase 2]

See pricing